Monthly Archives: October 2010

Researchers develop new tool to help predict the success of kidney transplants

A few simple questions can help patients and their physicians predict whether a kidney transplanted from a deceased donor will succeed long-term. “Surprisingly few new tools have been developed to predict outcomes after a kidney transplant,” Bertram Kasiske, MD, Hennepin County Medical Center, Minneapolis, MN and colleagues observe in a new study appearing in the [Sign in to read the full article...]

Nearly twice as many elderly patients are getting kidney transplants than 10-years ago, study finds

Elderly patients with kidney failure are almost twice as likely to get a kidney transplant than a decade ago, researchers reported. The results suggest the chances of receiving a kidney transplant are better than ever for an older patient who needs one, according to a study appearing in an upcoming issue of the Clinical Journal [Sign in to read the full article...]

Mapping functional connections between retinal neurons at single-cell resolution may lead to better retinal implants

By comparing a clearly defined visual input with the electrical input of the retina, researchers at the Salk Institute for Biological Studies report they were able to trace for the first time the neuronal circuitry that connects individual photoreceptors with retinal ganglion cells, the neurons that carry visual signals from the eye to the brain. [Sign in to read the full article...]

Researchers develop first implantable device for Meniere’s disease patients

An implantable device that could help patients with Meniere’s disease restore their balance has been developed by researchers. Meniere’s disease is a disorder of the inner ear that affects a person’s balance and hearing that occurs in less than one percent of the US population. Drs. Jay Rubinstein and James Phillips, both from the University [Sign in to read the full article...]

FDA’s Cellular, Tissue and Gene Therapies Advisory Committee to meet Nov. 19; meeting open to the public

The Food and Drug Administration (FDA) announced its Cellular, Tissue and Gene Therapies Advisory Committee will meet on Friday, November 19, 2010 from 8:30 a.m. to 5 p.m. at the Hilton Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD 20877. The general function of the committee is to provide advice to the agency on FDA’s [Sign in to read the full article...]